These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8707460)
81. The effect of glibenclamide on cutaneous laser-Doppler flux. Cankar K; Strucl M Microvasc Res; 2008 Jan; 75(1):97-103. PubMed ID: 17675187 [TBL] [Abstract][Full Text] [Related]
82. Study of arterial and autonomic effects of cyclosporine in humans. Lucini D; Milani RV; Ventura HO; Mehra MR; Messerli F; Pagani M Hypertension; 2000 Jun; 35(6):1258-63. PubMed ID: 10856274 [TBL] [Abstract][Full Text] [Related]
83. Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts. Wildhirt SM; Weis M; Schulze C; Conrad N; Pehlivanli S; Rieder G; Enders G; von Scheidt W; Reichart B Circulation; 2001 Sep; 104(12 Suppl 1):I336-43. PubMed ID: 11568079 [TBL] [Abstract][Full Text] [Related]
84. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy. Sánchez V; Delgado JF; Blasco T; Dalmau R; Morales JM; Escribano P; Tello R; Hernández J; Velázquez T; Sotelo T; Gómez-Sánchez MA; Sáenz de la Calzada C Transplant Proc; 1999 Sep; 31(6):2515-6. PubMed ID: 10500695 [No Abstract] [Full Text] [Related]
85. [Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases]. Guerci AP; Burtin P; Mattei S; Lederlin P Ann Med Interne (Paris); 1992; 143(3):155-9. PubMed ID: 1524349 [TBL] [Abstract][Full Text] [Related]
86. Renal hemodynamics in renal transplant recipients. The role of reduced kidney mass and cyclosporine administration. Pluvio C; DePascale E; Pluvio M; Carone M; Giordano M; Luzi L; Sabella F; Castellino P Transplantation; 1996 Mar; 61(5):733-8. PubMed ID: 8607176 [TBL] [Abstract][Full Text] [Related]
87. [Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation]. Vavić N; Ignjatović L; Drasković B; Hrvacević R; Kovacević Z; Paunić Z Vojnosanit Pregl; 2008 Feb; 65(2):119-27. PubMed ID: 18365668 [TBL] [Abstract][Full Text] [Related]
88. Generalised wavelet analysis of cutaneous flowmotion during post-occlusive reactive hyperaemia in patients with peripheral arterial obstructive disease. Rossi M; Bertuglia S; Varanini M; Giusti A; Santoro G; Carpi A Biomed Pharmacother; 2005 Jun; 59(5):233-9. PubMed ID: 15925479 [TBL] [Abstract][Full Text] [Related]
89. Altered cutaneous microvascular responses to reactive hyperaemia in coronary artery disease: a comparative study with conduit vessel responses. Shamim-Uzzaman QA; Pfenninger D; Kehrer C; Chakrabarti A; Kacirotti N; Rubenfire M; Brook R; Rajagopalan S Clin Sci (Lond); 2002 Sep; 103(3):267-73. PubMed ID: 12193152 [TBL] [Abstract][Full Text] [Related]
90. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients. Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465 [No Abstract] [Full Text] [Related]
91. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients. White M; Pelletier GB; Tan A; Jesina C; Carrier M J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770 [TBL] [Abstract][Full Text] [Related]
92. Is oral azithromycin effective for the treatment of cyclosporine-induced gingival hyperplasia in cardiac transplant recipients? Strachan D; Burton I; Pearson GJ J Clin Pharm Ther; 2003 Aug; 28(4):329-38. PubMed ID: 12911686 [TBL] [Abstract][Full Text] [Related]
93. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients. van den Dorpel MA; Veld AJ; Levi M; ten Cate JW; Weimar W Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1555-8. PubMed ID: 10364089 [TBL] [Abstract][Full Text] [Related]